Office location and address
Residency, University of Virginia School of Medicine (General Surgery)
Fellowship, University of Michigan School of Medicine (Transplant)
Shawn J. Pelletier, MD, is an associate professor in the Department of Surgery, Division of Transplantation Surgery at the University of Virginia Health System. Dr. Pelletier received his medical degree from Hahnemann University School of Medicine in Philadelphia, PA, in 1996. He completed his general surgery residency in 2003 at the University of Virginia. Dr. Pelletier went on to complete a two-year fellowship in transplantation surgery at the University of Michigan Health System, and in 2005, he joined the faculty at the University of Michigan. In 2007, he became the assistant director of the Multi-disciplinary Liver Tumor Clinic at the University of Michigan Comprehensive Cancer Center in Ann Arbor, MI. A year later, he became the surgical director of liver transplantation at the University of Michigan.
Dr. Pelletier returned to the University of Virginia in 2012 as the surgical director of liver transplantation. His clinical interests focus on living and deceased donor liver transplants, minimally invasive (laparoscopic) liver resection, as well as other aspects of hepatobiliary surgery. His research focuses on the outcomes following liver transplants and the development of donation following cardiac death.
He is board certified by the American Board of Surgery, and he is a fellow of the American College of Surgeons. Additionally, he's a member of professional and scientific societies, including the American Association for the Study of Liver Disease, the American Society of Transplant Surgeons, the International Liver Transplant Society, the International Liver Cancer Association and the American Hepato-Pancreato-Biliary Association. He is widely published in scientific and professional journals on topics related to his research and clinical experience. Dr. Pelletier has over ten years of experience as a principal investigator in basic and translational research and clinical trials. His research has been funded by the NIH/NIDDK as well as HRSA.